HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: LaPrairie Cellular Brightening

This article was originally published in The Rose Sheet

Executive Summary

LaPrairie Cellular Brightening: System "lightens" and "brightens" the complexion while offering sun protection, LaPrairie said. The collection includes four "advanced" products that "inhibit melanin production (melanogenesis) by not allowing the enzyme Tyrosinase to produce new melanin cells," the company claims. The lighteners are formulated with ingredients such as vitamin C-derivative magnesium ascorbyl phosphate, licorice extract, glycyrhetinate, glycoproteins, ginseng extract, green tea and AHAs. The "antioxidant activity of licorice combined with green tea helps prevent the formation of new brown spots," the firm claims. Products include Soothing lotion, Intensive Essence, Day Emulsion SPF 15 and Night Treatment. The line will be available in January at prices ranging from $65 for the soothing lotion to $125 for the night treatment...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004782

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel